Industry
MLYS’s Stochastic Averages Dip: Analyzing Mineralys Therapeutics Inc’s Stock Performance
The market performance of Mineralys Therapeutics Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $16.91 on 02/27/24, with the lowest value for the same timeframe being $7.95, recorded on 01/18/24. 52-week price history of MLYS Stock A
